UBS analyst lowered price target on McCormick, and Reuters reported on Toms Capital's stake in the company.
1 report, 1 independent
Updated Jun 17
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
UBS analyst lowered price target on McCormick, and Reuters reported on Toms Capital's stake in the company.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
McCormick & Company
spice, herb, and flavoring manufacturing company headquartered in Sparks, Maryland
-
UBS
Swiss multinational investment bank and financial services company
Related events
- Analyst firms Mizuho, UBS, and Morgan Stanley raised price targets for Five Below on September 4, 2026.
- UBS analysts focused on Costco's membership growth while Bank of America trimmed its price target due to a cautious view.
- UBS raised its price target on SolarEdge stock on August 25, 2025.
- Analyst action influenced stock price targets for companies including UBS, Alphabet Inc., Cantor Fitzgerald, and JPMorgan Chase.
- MiniMed Group received multiple target price increases from UBS, Morgan Stanley, and Deutsche Bank, and submitted a product to the FDA.